Skip to main content

gotistobart

Generic: Gotistobart

gotistobart: 2 clinical trials tracked.

gotistobart evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about gotistobart, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Non-Small Cell Lung Cancer
Clinical Trial Registry Records (2)

Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510Registry updated 2026-08-13·Phase 3
Active, not recruiting

Primary endpoint: Overall Survival (OS)

InterventionalRandomizedopen630 targetStarted 2023-06Completion 2028-0850 sites · Australia, United StatesOncoC4, Inc.

LuCa-MERIT-1: First-in-human, Open Label, Phase I Dose Confirmation Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

NCT05142189Registry updated 2026-07-22·Phase 1·BNTX
Recruiting

Primary endpoint: Cohorts 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, EGFR and ALK/RET: Occurrence of Dose-Limiting Toxicities (DLTs) During the DLT Observation Period

Interventionalopen320 targetStarted 2022-06Completion 2031-1145 sites · Australia, Germany, Hungary, Poland…BioNTech SE